VERA - CIK 0001831828
Vera Therapeutics, Inc. has filed 447 documents with the SEC between 2021 and 2026. The most frequent type is insider trade (186 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider trade | 4 | 2026-05-26 | 2026-05-21 |
| Insider trade | 4 | 2026-05-26 | 2026-05-21 |
| Insider trade | 4 | 2026-05-26 | 2026-05-21 |
| Insider trade | 4 | 2026-05-26 | 2026-05-21 |
| Insider trade | 4 | 2026-05-26 | 2026-05-21 |
| Insider trade | 4 | 2026-05-26 | 2026-05-21 |
| Insider trade | 4 | 2026-05-26 | 2026-05-21 |
| Major company event | 8-K | 2026-05-26 | 2026-05-21 |
| Insider trade | 4 | 2026-05-26 | 2026-05-21 |
| SCHEDULE 13G/A | - | 2026-05-15 | - |
| Insider trade | 4 | 2026-05-13 | 2026-05-12 |
| Insider sale notice | 144 | 2026-05-12 | - |
| Quarterly report | 10-Q | 2026-05-07 | 2026-03-31 |
| Major company event | 8-K | 2026-05-07 | 2026-05-07 |
| Insider trade | 4 | 2026-04-15 | 2026-04-14 |
| Insider sale notice | 144 | 2026-04-14 | - |
| Annual report to shareholders | ARS | 2026-04-09 | 2025-12-31 |
| Proxy materials | DEFA14A | 2026-04-09 | - |
| Proxy statement | DEF 14A | 2026-04-09 | 2026-05-21 |
| SCHEDULE 13G | - | 2026-04-01 | - |
| SCHEDULE 13G/A | - | 2026-03-27 | - |
| Insider trade | 4 | 2026-03-25 | 2026-03-23 |
| New insider ownership | 3 | 2026-03-25 | 2026-03-23 |
| Insider trade | 4 | 2026-03-16 | 2026-03-13 |
| SCHEDULE 13G | - | 2026-03-11 | - |
| Insider trade | 4 | 2026-03-09 | 2026-03-05 |
| New insider ownership | 3 | 2026-03-09 | 2026-03-05 |
| Major company event | 8-K | 2026-03-09 | 2026-03-05 |
| SCHEDULE 13D/A | - | 2026-03-05 | - |
| Employee stock plan | S-8 | 2026-02-27 | - |
| Annual report | 10-K | 2026-02-26 | 2025-12-31 |
| Major company event | 8-K | 2026-02-26 | 2026-02-26 |
| Insider trade | 4 | 2026-02-25 | 2026-02-23 |
| Insider trade | 4 | 2026-02-25 | 2026-02-23 |
| Insider trade | 4 | 2026-02-25 | 2026-02-23 |
| Insider trade | 4 | 2026-02-25 | 2026-02-23 |
| Insider trade | 4 | 2026-02-25 | 2026-02-23 |
| Insider trade | 4 | 2026-02-25 | 2026-02-23 |
| Insider trade | 4 | 2026-02-25 | 2026-02-23 |
| Insider sale notice | 144 | 2026-02-23 | - |
| Insider sale notice | 144 | 2026-02-23 | - |
| Insider sale notice | 144 | 2026-02-23 | - |
| Insider sale notice | 144 | 2026-02-23 | - |
| Insider sale notice | 144 | 2026-02-23 | - |
| Insider sale notice | 144 | 2026-02-23 | - |
| SCHEDULE 13G/A | - | 2026-02-17 | - |
| Insider trade | 4 | 2026-02-06 | 2026-02-04 |
| Insider trade | 4 | 2026-02-06 | 2026-02-04 |
| Insider trade | 4 | 2026-02-06 | 2026-02-04 |
| Insider trade | 4 | 2026-02-06 | 2026-02-04 |